Following 8 successful years, the Immunogenicity and Bioassay Summit is expanding to include SIX short courses, TWO training seminars, AND a one-day immersive symposium in addition to our THREE conference tracks. These events provide an invaluable opportunity to learn how the experts manage the challenges of Immunogenicity Assessment, Prediction and Risk Mitigation, as well as Bioanalytical and Bioassay Development. Once again, attendees will hear from the regulatory authorities and be able to discuss their challenges with them. NEW this year is a focus on Bioassays for Immuno-Oncology, Immunology for Scientists in Biotherapeutic Discovery and Development, and an Introduction to Design of Experiments.
Abzena will be presenting at the conference.